Lupin Ltd LUPIN-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:29 PM IST
1,189.15quote price arrow up+10.70 (+0.91%)
Volume
2,610,218
52 week range
828.40 - 1,246.80

...

Loading . . .
  • Open1,194.00
  • Day High1,194.00
  • Day Low1,170.00
  • Prev Close1,178.45
  • 52 Week High1,246.80
  • 52 Week High Date05/11/21
  • 52 Week Low828.40
  • 52 Week Low Date07/27/20

Key Stats

  • Market Cap7,303.95M
  • Shares Out453.73M
  • 10 Day Average Volume6.56M
  • Dividend6.00
  • Dividend Yield0.50%
  • Beta
  • YTD % Change18.66

KEY STATS

  • Open1,194.00
  • Day High1,194.00
  • Day Low1,170.00
  • Prev Close1,178.45
  • 52 Week High1,246.80
  • 52 Week High Date05/11/21
  • 52 Week Low828.40
  • 52 Week Low Date07/27/20
  • Market Cap7,303.95M
  • Shares Out453.73M
  • 10 Day Average Volume6.56M
  • Dividend6.00
  • Dividend Yield0.50%
  • Beta
  • YTD % Change18.66

RATIOS/PROFITABILITY

  • EPS (TTM)26.84
  • P/E (TTM)44.31
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/03/2020
  • Div Amount6.00
  • Split Date-
  • Split Factor-

Latest On Lupin Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and non-steroidal anti-inflammatory drug therapy areas. The Company also offers solutions in the...
Manju Gupta
Chairman
Vinita Gupta
Chief Executive Officer
Ramesh Swaminathan
Chief Financial Officer
Address
B/4 Laxmi Towers
, Bandra Kurla Complex, Bandra (E)
Mumbai
400051
India